(Q73687250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Aerosolized dornase alfa in cystic fibrosis: is there a role in the management of patients with early obstructive lung disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

D E Geller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Pediatric Pulmonology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

155-8; discussion 159-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Lung deposition from four nebulizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Aerosol delivery to the rabbit lung with an infant ventilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

The delivery of therapeutic aerosols through endotracheal tubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Pulmonary deposition of aerosols in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Quantitative deposition of aerosolized gentamicin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199708%2924%3A2%3C155%3A%3AAID-PPUL16%3E3.0.CO%3B2-1

10.1002/(SICI)1099-0496(199708)24:2<155::AID-PPUL16>3.0.CO;2-1

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9292913%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference